The Diabetes Drugs Market, valued as a USD 20 billion market in 2010, is expected to grow at an exponential rate and become a USD 32 billion market by 2017, at a CAGR of about 7.5%.
Visit For More Information In-Depth With Full TOC @ http://orianresearch.com/report/global-diabetes-drugs-market-growth-trends-and-forecasts-2017-2022
Diabetes, often referred to by doctors as diabetes mellitus, describes a group of metabolic diseases in which the person has high blood glucose (blood sugar), either because insulin production is inadequate, or because the body’s cells do not respond properly to insulin or both.
To Get Free Sample Report Visit @ http://orianresearch.com/request-sample/Global-Diabetes-Drugs-Market-Growth-Trends-and-Forecasts-2017-2022
Cost sensitivity issues
The market is segmented on the basis of diabetic drugs, devices, and geography. The diabetic drugs market is again segmented into categories, which are insulin derivatives and oral diabetic medication drugs. On the basis of geography, the market is segmented into North America, Europe, APAC and the Rest of the World.
Global Diabetes Drugs Market- Market Dynamics
This report studies the current as well as the future scenario of the diabetes diagnostic devices and drugs market globally. The report details several driving and restraining factors for this market. Some of them are listed below.
- Some of the factors driving the growth of this market are:
- Rise in the number of diabetics
- Complexities in alternative diabetic therapies
Some of the key players in the market are:
- Abbott Laboratories
- AstraZeneca PLC
- Johnson & Johnson
Key Deliverables in the Study
Market analysis for the diabetes drugs market, with region-specific assessments and competition analysis on the global and regional scale.
Market definition along with the identification of key drivers and restraints.
Identification of factors instrumental in changing the market scenario, rising prospective opportunities, and identification of key companies that can influence this market on a global and regional scale.
Extensively researched competitive landscape section with profiles of major companies along with their market share.
Identification and analysis of the macro and micro factors that affect the market on both global and regional scale.
Access More Information On This Report With Full TOC –
Table of Contents
1.1 Report Description
1.2 Research Methodology
- EXECUTIVE SUMMARY
2.1 Key Findings
2.2 Market Overview
- MARKET OVERVIEW
3.1 Market Definition
3.2 Market Segmentation
3.3 Market Drivers
- GLOBAL MARKETS: SEGMENTATION BY DRUGS
4.1 Insulin Derivatives
4.1.1 Rapid-acting insulin
4.1.2 Intermediate-acting insulin
4.1.3 Long-acting insulin
4.2 Oral Diabetic Medication Drugs
- GLOBAL MARKETS: SEGMENTATION BY GEOGRAPHY
5.1 North America
- COMPETITIVE LANDSCAPE
6.2 Mergers & Acquisitions
6.4 New Product Launch
- COMPANY PROFILES
7.1 Abbott Laboratories
7.2 AstraZeneca PLC
7.3 Bayer Healthcare AG
7.4 Dexcom Inc
7.5 GlaxoSmithKline PLC
Vice President – Global Sales
+1 (832) 380-8827